Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: A retrospective study

European Journal of Surgical Oncology

Volumn 39, Issue 8, 2013, Pages 865-872

  Dan, J Q ^a   Zhang, Y J ^a   Huang, J T ^a   Chen, M S ^a   Gao, H J ^a   Peng, Z W ^a   Xu, L ^a   Lau, W Y ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatic resection; Hepatitis B virus DNA; Hepatitis B virus reactivation; Hepatocellular carcinoma; Radiofrequency ablation

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; LIVER CELL CARCINOMA; LIVER RESECTION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REINFECTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS REACTIVATION;

HEPATIC RESECTION; HEPATITIS B VIRUS DNA; HEPATITIS B VIRUS REACTIVATION; HEPATOCELLULAR CARCINOMA; RADIOFREQUENCY ABLATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84879837707     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.03.020     Document Type: Article

References (30)

1. J. Ferlay, H.R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. C.J. Chen, H.I. Yang, and J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
3. G. Lalazar, D. Rund, and D. Shouval Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Br J Haematol 136 2007 699 712
4. M. Ozguroglu, A. Bilici, H. Turna, and S. Serdengecti Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma Med Oncol 21 2004 67 72
5. W. Yeo, K.C. Lam, and B. Zee Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy Ann Oncol 15 2004 1661 1666
6. X.M. Lao, D. Wang, and M. Shi Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma Hepatol Res 41 2011 553 563
7. L. Huang, J. Li, and W.Y. Lau Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma J Gastroenterol Hepatol 27 2012 158 164
8. R. Lencioni, D. Cioni, and L. Crocetti Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967
9. R. Tateishi, S. Shiina, and T. Teratani Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 2005 1201 1209
10. S. Mulier, P. Mulier, and Y. Ni Complications of radiofrequency coagulation of liver tumours Br J Surg 89 2002 1206 1222
11. W.Y. Lau, T.W. Leung, S.C. Yu, and S.K. Ho Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future Ann Surg 237 2003 171 179
12. M.S. Chen, J.Q. Li, and Y. Zheng A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
13. L. Lupo, P. Panzera, and G. Giannelli Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9 2007 429 434
14. A. Guglielmi, A. Ruzzenente, and A. Valdegamberi Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis J Gastrointest Surg 12 2008 192 198
15. S.N. Hong, S.Y. Lee, and M.S. Choi Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function J Clin Gastroenterol 39 2005 247 252
16. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
17. Z.W. Peng, Y.J. Zhang, and M.S. Chen Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results Eur J Surg Oncol 36 2010 1054 1060
18. M. Makuuchi, H. Hasegawa, and S. Yamazaki Ultrasonically guided subsegmentectomy Surg Gynecol Obstet 161 1985 346 350
19. EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
20. W. Yeo, P.K. Chan, and S. Zhong Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors J Med Virol 62 2000 299 307
21. W. Yeo, and P.J. Johnson Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy Hepatology 43 2006 209 220
22. S. Kubo, S. Nishiguchi, and H. Hamba Reactivation of viral replication after liver resection in patients infected with hepatitis B virus Ann Surg 233 2001 139 145
23. R.F. Sanchez-Ortiz, N. Tannir, K. Ahrar, and C.G. Wood Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol 170 2003 178 179
24. P. Rao, B. Escudier, and T. de Baere Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis Cardiovasc Intervent Radiol 34 2011 424 430
25. F.F. Fagnoni, A. Zerbini, G. Pelosi, and G. Missale Combination of radiofrequency ablation and immunotherapy Front Biosci 13 2008 369 381
26. M.H. den Brok, R.P. Sutmuller, and R. van der Voort In situ tumor ablation creates an antigen source for the generation of antitumor immunity Cancer Res 64 2004 4024 4029
27. T. Kuzuya, Y. Katano, and T. Kumada Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma J Gastroenterol Hepatol 22 2007 1929 1935
28. H. Yoshida, H. Yoshida, and E. Goto Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma Hepatol Int 2 2008 89 94
29. M. Chuma, S. Hige, and T. Kamiyama The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma J Gastroenterol 44 2009 991 999
30. G. Huang, E.C. Lai, and W.Y. Lau Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels Ann Surg 257 2013 490 505